EverEdge Global
headquartered in New Zealand, publishes valuation models spanning ten distinct IP asset classes relevant to pharmaceutical and biotech portfolios.
- Country
- NZ
EU
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| regulatory-legal | ✓ | ✓ | ✓ | ✓ |
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biotech IP valuation | regulatory-legal | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.